Director of the National Institutes of Health
Executive orders directing the Director of the National Institutes of Health · 7 in Search.
Related departments
Orders
7 shown
Addressing Addiction Through the Great American Recovery Initiative
This executive order establishes the White House Great American Recovery Initiative, co-chaired by the Secretary of HHS and a Senior Advisor for Addiction Recovery, to coordinate federal response to substance use disorder. The Initiative brings together 15+ officials across cabinet departments and agencies to recommend steps for aligning federal programs, increasing treatment access, and integrating addiction services across health, criminal justice, workforce, education, and housing systems.
Increasing Medical Marijuana and Cannabidiol Research
This executive order directs the Attorney General to expedite rescheduling marijuana from Schedule I to Schedule III of the Controlled Substances Act to facilitate medical research. It also directs multiple health agencies to develop research methods using real-world evidence for medical marijuana and hemp-derived CBD products, and tasks White House legislative staff with working Congress to update statutory definitions for hemp-derived cannabinoids.
Unlocking Cures for Pediatric Cancer With Artificial Intelligence
This executive order directs the Make America Healthy Again (MAHA) Commission and health agencies to leverage artificial intelligence to accelerate pediatric cancer research, diagnosis, and treatment. It builds on the existing Childhood Cancer Data Initiative (CCDI) by mandating AI-driven improvements to data infrastructure, clinical trial design, and interoperability standards while prioritizing federal investment and private-sector engagement.
Improving and Expanding Access to Care and Treatments for COVID-19
This executive order directs federal agencies to accelerate COVID-19 treatment development, expand healthcare system capacity through targeted surge assistance to long-term care facilities, and improve access to affordable care by evaluating insurance coverage programs and establishing production targets for therapeutics. It emphasizes supporting rural hospitals, historically underrepresented clinical trial populations, and patients with long-term COVID effects.
Protecting the Federal Workforce and Requiring Mask-Wearing
This executive order mandates that on-duty or on-site federal employees, contractors, and visitors wear masks and follow CDC public health guidelines in federal buildings and on federal lands. It also establishes the Safer Federal Workforce Task Force to provide ongoing guidance on COVID-19 workplace safety and requires federal agencies to report on their implementation progress.
White House Cancer Moonshot Task Force
This memorandum establishes the White House Cancer Moonshot Task Force, chaired by the Vice President, to coordinate federal efforts to accelerate cancer research, treatment, and prevention. The Task Force includes heads of 14 executive departments and agencies and is directed to produce findings and recommendations on accelerating research, improving patient care, reducing regulatory barriers, and developing public-private partnerships, with a report due to the President by December 31, 2016.
Expanding Approved Stem Cell Lines in Ethically Responsible Ways
This executive order directs HHS and NIH to intensify research on pluripotent stem cells derived from sources that do not involve creating or destroying human embryos. It requires a 90-day implementation plan and annual reporting, while renaming the Human Embryonic Stem Cell Registry to reflect broader cell sources.